SPL 1.02% 9.9¢ starpharma holdings limited

BV market for prevention

  1. 357 Posts.
    lightbulb Created with Sketch. 31
    Ok lets crunch some numbers, very rough of course.

    Global BV market estimated to be 1 billion.
    Assumptions:
    1. We will not be marketed globally.
    2. We will not have 100% market penetration.
    3. We will not get 100% of the revenue, we will likely get circa 8% (very rough estimation that others can subsitute).

    So what % of the global market do we expect to access? I'll give it a generous 50% weighting.
    % market penetration i'll give it a generous 70%
    8% cut of sales.

    500 000 000 x 0.7 . 0.08 = $28 million in revenue for us per year in full swing.

    Before we get to full swing I estimate we get 2/5ths of well you know what.

    Please create your own formulae's of potential revenue to share from Vivagel, I'll be greatly interested to see your own estimates.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
0.001(1.02%)
Mkt cap ! $41.39M
Open High Low Value Volume
9.8¢ 9.9¢ 9.8¢ $20.16K 203.8K

Buyers (Bids)

No. Vol. Price($)
1 9097 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 255005 11
View Market Depth
Last trade - 11.18am 07/11/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.